Related Experiment Videos
Weekly low-dose methotrexate therapy for sarcoidosis
1Department of Internal Medicine, Hamamatsu University School of Medicine.
Internal Medicine (Tokyo, Japan)
|July 1, 1994
Summary
Low-dose methotrexate is an effective treatment for sarcoidosis, particularly for patients unresponsive to steroids. This therapy offers significant clinical improvement with minimal side effects, presenting a viable alternative for managing this chronic inflammatory condition.
Area of Science:
- Rheumatology
- Immunology
- Pulmonology
Background:
- Sarcoidosis is a multisystemic inflammatory disease with limited treatment options.
- Low-dose methotrexate is a recognized therapy for various chronic inflammatory conditions.
Observation:
- A patient with symptomatic sarcoidosis refractory to corticosteroid treatment was identified.
- This patient received low-dose methotrexate for their condition.
Findings:
- The patient experienced significant clinical improvement following low-dose methotrexate therapy.
- No severe adverse effects were observed during the treatment period.
Implications:
- Low-dose methotrexate may serve as a safe and effective alternative treatment for sarcoidosis.
- Further research into methotrexate's efficacy for sarcoidosis is warranted.